EducationNCT05845957
Digital Storytelling in Pediatric Safe Drug
A study testing Digital Education Group in people with Education and Nursing, run by Ege University at 1 site in Turkey (Türkiye).
Trial summary
Summary Aim: This research was conducted to determine the effectiveness of education given to students using digital storytelling in safe pediatric intravenous drug administration. Method: It is a randomized controlled experimental study. The sample of the study consisted of 84 nursing students. Read more about this study
- Who is it for?
- Ages 19 to 23 yearsHealthy volunteers can take part
- Conditions the study is for
- Education, Nursing, Innovativeness
- What is being tested?
- Digital Education Group
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 84 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 8 Dec 2021to 6 Apr 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 to 23 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Being a student of the Department of Nursing
- Taking the child health and diseases nursing course and being successful
- Volunteering to participate in the research
Who cannot join
- Participate and quit the study
- Being a 1st and 2nd year nursing student
- Failure of the child health and diseases nursing course
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Efficiency of Education Given to Students With Digital Storytelling in Safe Pediatric Intravenous Drug Administration
Summary Aim: This research was conducted to determine the effectiveness of education given to students using digital storytelling in safe pediatric intravenous drug administration.
Method: It is a randomized controlled experimental study. The sample of the study consisted of 84 nursing students. The students included in the study were divided into two equal groups: the experimental and control groups. Digital education material of the experimental group and theoretical education was applied to the control group. Before and after the training, a post-knowledge test was made and evaluated.
- Conditions
- Education, Nursing, Innovativeness
- Being tested
- Digital Education Group
- Keywords
- Nursing students, Education, Digital stroytelling, pediatrics, safe drug application
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Digital Education GroupOther
Providing training on safe pediatric intravenous drug administration with digital storytelling method
| Study group | Role | What they receive |
|---|---|---|
| Digital Education Group | Experimental | All participants in this group were given the "Safe pediatric intravenous drug administration knowledge test" prepared by the researchers as a pre-test.
The participants of this group, who were determined by randomization, were given training prepared using the digital storytelling method. The training took 25 minutes.
After the training, the "Safe intravenous drug administration knowledge test" was applied as a post-test. Receives: Other: Digital Education Group |
| Control Group | No intervention | No intervention was made. All participants in this group were given the "Safe pediatric intravenous drug administration knowledge test" prepared by the researchers as a pre-test. Afterward, theoretical information on the subject was given. After theoretical information, the "Safe intravenous drug administration knowledge test" was applied as a post-test. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Statistical difference between groups about knowledge test scores
Safe pediatric drug practices knowledge test is applied twice as pre-test and post-test in experimental and control groups.
Safe pediatric drug practices knowledge test: It is a 17-question form prepared by researchers. Content validity has been made for the form. Each correct answer is calculated as 1 point and each wrong answer is calculated as 0 points. The higher the score obtained from the questionnaire, the higher the level of knowledge.
Measured: During the education, approximately 25 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 May 2023
- Study start8 Dec 2021
- Primary completion30 Apr 2022
- Study completion6 Apr 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for EducationStudies of the same condition, open and under way.
- More trials run by Ege UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The research was a randomized controlled, experimental study.
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 84 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ege University
- Sponsor type
- University, hospital or other
- Collaborators
- Izmir Bakircay University
- Responsible party
- Principal investigator, Şeyda BİNAY YAZ, Ege University
- Investigators
- Semih Akkoyun, Principal investigator, Izmir Bakircay University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05845957
- Sponsor's protocol ID
- Bakircay
- Status last verified
- May 2023
- First submitted
- 17 Apr 2023
- Last updated
- 6 May 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The study will be prepared for publication
Study at a glance
From the registry record, last updated by the sponsor on 6 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Efficiency of Education Given to Students With Digital Storytelling in Safe Pediatric Intravenous Drug Administration
- ClinicalTrials.gov ID
- NCT05845957
- Acronym / sponsor ID
- Bakircay
- Conditions
- Education, Nursing, Innovativeness
- Keywords
- Nursing students, Education, Digital stroytelling, pediatrics, safe drug application
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 84 participants (actual)
- Lead sponsor
- Ege UniversityUniversity, hospital or other
- Collaborators
- Izmir Bakircay University
- Study start
- 8 Dec 2021 (actual)
- Primary completion
- 30 Apr 2022 (actual)
- Study completion
- 6 Apr 2023 (actual)
- First posted
- 6 May 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Summary Aim: This research was conducted to determine the effectiveness of education given to students using digital storytelling in safe pediatric intravenous drug administration.
Method: It is a randomized controlled experimental study. The sample of the study consisted of 84 nursing students. The students included in the study were divided into two equal groups: the experimental and control groups. Digital education material of the experimental group and theoretical education was applied to the control group. Before and after the training, a post-knowledge test was made and evaluated.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 2
- Model description
- The research was a randomized controlled, experimental study.
| Arm | Type | Receives |
|---|---|---|
| Digital Education Group | Experimental | Other: Digital Education GroupAll participants in this group were given the "Safe pediatric intravenous drug administration knowledge test" prepared by the researchers as a pre-test. The participants of this group, who were determined by randomization, were given training prepared using the digital storytelling method. The training took 25 minutes. After the training, the "Safe intravenous drug administration knowledge test" was applied as a post-test. |
| Control Group | No intervention | –No intervention was made. All participants in this group were given the "Safe pediatric intravenous drug administration knowledge test" prepared by the researchers as a pre-test. Afterward, theoretical information on the subject was given. After theoretical information, the "Safe intravenous drug administration knowledge test" was applied as a post-test. |
Who may qualify
- Ages
- 19 to 23 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Being a student of the Department of Nursing
- Taking the child health and diseases nursing course and being successful
- Volunteering to participate in the research
Key exclusion criteria (3 listed)
- Participate and quit the study
- Being a 1st and 2nd year nursing student
- Failure of the child health and diseases nursing course
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Digital Education GroupProviding training on safe pediatric intravenous drug administration with digital storytelling method | Other | Digital Education Group |
Primary outcome
Statistical difference between groups about knowledge test scores
Time frame: During the education, approximately 25 minutes
Safe pediatric drug practices knowledge test is applied twice as pre-test and post-test in experimental and control groups. Safe pediatric drug practices knowledge test: It is a 17-question form prepared by researchers. Content validity has been made for the form. Each correct answer is calculated as 1 point and each wrong answer is calculated as 0 points. The higher the score obtained from the questionnaire, the higher the level of knowledge.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 May 2023.
- Individual participant dataSharing planned: No. The study will be prepared for publication
Related trials for Education
Not yet recruitingObservational study
Validation of the Healthcare Relationship Assessment Scale (ERA) in Health Sciences Students.
Health Adult Subjects, Communication
RecruitingEarly Phase 1
Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making
Normal Physiology
Recruiting
Evaluation of a French Hospital Discharge Therapeutic Education Program by Nurses for Heart Failure Patient (EduSor)
Heart Failure
Recruiting
Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Not yet recruiting
Mobile Game-Based Versus Classic First Aid Education in Adolescents: Randomized Controlled Trial
First Aid, Health Education in Schoolchildren
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Semih Akkoyun principal investigator
Izmir Bakircay University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Digital Education Group in people with Education and Nursing, run by Ege University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 May 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Statistical difference between groups about knowledge test scores (time frame: During the education, approximately 25 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2023.